HOME >> MEDICINE >> NEWS
A threatened St. Johns wort plant could be more effective as an anti-depressant, Cornell and USDA researchers find

ver, not all St. John's wort products are the same. Previous studies have shown that the amount of hypericin in the plant - although usually labeled can vary from plant to plant, manufacturer to manufacturer, bottle to bottle and pill to pill. Thus Sirvent and Gibson are trying to determine how much of a role pre-harvest factors play in chemical differences. They are examining factors such as light, moisture, altitude and latitude; the plant parts; the plant's development stage; and the harvesting and handling practices that might affect the quality of the final product. Additionally, variations in St. John's wort products sometimes occur because manufacturers mix species of H. perforatum.

The plant typically is gathered as a weedy species in the western United States, but some is being grown commercially in the Pacific Northwest. It also is found along roadways and in fields in the eastern United States. Hypericin is concentrated in little black nodules nearly imperceptible to the untrained eye that adorn the floral edges and the plant's leaves. Curiously, St. John's wort is considered a noxious weed that can cause hypericism, or blistering and dyeing of an animal's skin when it is eaten. Its scraggly, almost frail-looking stem produces a brilliant yellow flower cluster and it grows readily in rock quarries and in marginal areas such as roadsides, where little else grows.


'"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-255-3290
Cornell University News Service
14-Aug-2000


Page: 1 2

Related medicine news :

1. Caregivers refuse Alzheimers medications when patients quality of life threatened
2. Johns Hopkins scientists receive presidential medals
3. Robert Wood Johnson Medical School researcher receives fellowship for work in Canavan Disease
4. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
5. Federal institutes and the Robert Wood Johnson Foundation create Tobacco Use Research Centers
6. Johns Hopkins To Announce AIDS Capitated Care Program
7. Success of liver transplantation may be most influenced by three risk factors
8. Tracking trends in cochlear implant complications using a federal database
9. Alcohol relapse adversely affects 10-year liver transplant survival
10. Donor age has no affect on long-term liver transplant survival
11. Age shouldnt be a factor in kidney transplantation

Post Your Comments:
(Date:7/29/2014)... new lung is grown for a patient in need, using ... injection of replacement cells will enable a patient to self-heal ... ALERT: For audio and video of Dr. Keller and Jorge ... Mayo Clinic News Network . , Regenerative ... gift from Jorge and Leslie Bacardi of the Bahamas will ...
(Date:7/29/2014)... Dallas, Texas (PRWEB) July 29, 2014 ... the Global Biosimilars Market report is an essential ... biosimilars industry. Using detailed company data, financial analysis, ... in-depth analysis of the current and future growth ... the various regulatory frameworks under which biosimilars are ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Affordable ... reimbursement model of all hospitals. Studies show that over ... One simple, easy, low cost tool that great hospitals ... by 20 to 25%. , Their secret? Debriefing - ... anther at the end of an operational event. Debriefing ...
(Date:7/29/2014)... day lead to a more streamlined process for obtaining stem ... of replacement tissue for failing body parts, according to UC ... edition of Cell . , The work builds on ... embryonic state in which they again have the potential to ... this process may soon increase thanks to the scientists, identification ...
(Date:7/29/2014)... Little Rock, AR (PRWEB) July 29, 2014 ... S.Res.518 , a resolution declaring the week of October ... the value of case management in improving healthcare outcomes ... Pryor (D-AR) and Senator John Boozman (R-AR), with support ... American Case Management Association to honor case management professionals ...
Breaking Medicine News(10 mins):Health News:Bacardis make gift to significantly advance Mayo Clinic's regenerative medicine research 2Health News:Bacardis make gift to significantly advance Mayo Clinic's regenerative medicine research 3Health News:Bacardis make gift to significantly advance Mayo Clinic's regenerative medicine research 4Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 3Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 4Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 2Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 3Health News:Stem cell advance may increase efficiency of tissue regeneration 2Health News:Stem cell advance may increase efficiency of tissue regeneration 3Health News:CMSA Supports National Case Management Week Resolution Introduced in US Senate 2
(Date:7/29/2014)... Cynosure, Inc. (Nasdaq: CYNO ), which ... for high-volume applications, today reported financial results for the ... results incorporate the acquisition of Palomar Medical Technologies, which ... Second-Quarter 2014 Financial Highlights , ... Non-GAAP net income of $7.1 million, or $0.32 per ...
(Date:7/29/2014)... --   What:   AFFiRiS AG, ... from a Phase I clinical trial of PD01A, a ... disease progression. The Michael J. Fox Foundation supported the ... the impact of the results for patients and the ... 2014         11.00 am ...
(Date:7/29/2014)... VIEW, Calif. , July 29, 2014 /PRNewswire/ ... has amplified with rising incidence rates and the ... of a preventative vaccine. Change is underway as ... interferon regimens towards highly effective, easily-tolerated, interferon-free oral ... Gilead,s mega blockbuster Sovaldi ...
Breaking Medicine Technology:Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4
Cached News: